GB2054371A — Long-acting parenteral compositions of haloperidol and bromperidol derivatives
Assigned to Janssen Pharmaceutica NV · Expires 1981-02-18 · 45y expired
What this patent protects
Long-acting neuraleptic compositions for parenteral, in particular intramuscular or subcutaneous, administration, comprise a decanoate ester of haloperidol or bromperidol in sesame oil as a solvent. The esters may be prepared by known methods.
USPTO Abstract
Long-acting neuraleptic compositions for parenteral, in particular intramuscular or subcutaneous, administration, comprise a decanoate ester of haloperidol or bromperidol in sesame oil as a solvent. The esters may be prepared by known methods.
Drugs covered by this patent
- Aristada (ARIPIPRAZOLE LAUROXIL) · Alkermes Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.